Corticotroph adenoma in the dog: Pathogenesis and new therapeutic possibilities
Authors:
- V.A. CastilloVCV.A. Castillo
- M.F. GallelliMGM.F. Gallelli
- 1 February 2010
- journal article
- review article
- Published by Elsevier in Research in Veterinary Science
- Vol. 88 (1) , 26-32
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Cushing’s disease in dogs: Cabergoline treatmentResearch in Veterinary Science, 2008
- Expression and Functional Analysis of Dopamine Receptor Subtype 2 and Somatostatin Receptor Subtypes in Canine Cushing’s DiseaseEndocrinology, 2008
- The desmopressin stimulation test in dogs with Cushing's syndromeDomestic Animal Endocrinology, 2007
- Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostaneDomestic Animal Endocrinology, 2006
- A Comparison of the Survival Times of Dogs Treated with Mitotane or Trilostane for Pituitary-Dependent HyperadrenocorticismJournal of Veterinary Internal Medicine, 2005
- The peroxisome proliferator-activated receptor ? ligand troglitazone induces apoptosis and p53 in rat granulosa cellsMolecular and Cellular Endocrinology, 2005
- Pituitary cell lines and their endocrine applicationsMolecular and Cellular Endocrinology, 2004
- Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140Molecular and Cellular Endocrinology, 2004
- Therapy of Cushing's syndrome with steroid biosynthesis inhibitorsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Effects of an Rb mutation in the mouseNature, 1992